6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate

C125H149N37O12S2 — CID 159361739

IUPAC6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate
SMILESCC(=O)N(C)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CN(C)S(=O)(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CN(C=O)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CNc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.COC(=O)N(C)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.COC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CS(=O)(=O)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.NC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2
InChIInChI=1S/C15H18N4O2.C15H18N4O.C14H19N5O2S.C14H16N4O2.2C14H16N4O.C13H15N5O.C13H16N4.C13H15N3O2S/c1-18(15(20)21-2)13-4-3-11-5-6-19(14(11)7-13)9-12-8-16-10-17-12;1-11(20)18(2)14-4-3-12-5-6-19(15(12)7-14)9-13-8-16-10-17-13;1-18(2)22(20,21)17-12-4-3-11-5-6-19(14(11)7-12)9-13-8-15-10-16-13;1-20-14(19)17-11-3-2-10-4-5-18(13(10)6-11)8-12-7-15-9-16-12;1-17(10-19)13-3-2-11-4-5-18(14(11)6-13)8-12-7-15-9-16-12;1-10(19)17-12-3-2-11-4-5-18(14(11)6-12)8-13-7-15-9-16-13;14-13(19)17-10-2-1-9-3-4-18(12(9)5-10)7-11-6-15-8-16-11;1-14-11-3-2-10-4-5-17(13(10)6-11)8-12-7-15-9-16-12;1-19(17,18)12-3-2-10-4-5-16(13(10)6-12)8-11-7-14-9-15-11/h3-4,7-8,10H,5-6,9H2,1-2H3,(H,16,17);3-4,7-8,10H,5-6,9H2,1-2H3,(H,16,17);3-4,7-8,10,17H,5-6,9H2,1-2H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,15,16)(H,17,19);2-3,6-7,9-10H,4-5,8H2,1H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,15,16)(H,17,19);1-2,5-6,8H,3-4,7H2,(H,15,16)(H3,14,17,19);2-3,6-7,9,14H,4-5,8H2,1H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,14,15)
InChIKeyLIPZOYVNGNGUSA-UHFFFAOYSA-N
MW2425.95 g/mol
LogP15.82
Rot. Bonds30

About 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate

6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate (PubChem CID 159361739) has the molecular formula C125H149N37O12S2 and a molecular weight of 2425.95 g/mol. Its IUPAC name is 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate.

Molecular Properties

Compound Name6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate
PubChem CID159361739
Molecular FormulaC125H149N37O12S2
Molecular Weight2425.95 g/mol
Exact Mass2424.16
IUPAC Name6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate
SMILESCC(=O)N(C)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CN(C)S(=O)(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CN(C=O)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CNc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.COC(=O)N(C)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.COC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CS(=O)(=O)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.NC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2
InChIInChI=1S/C15H18N4O2.C15H18N4O.C14H19N5O2S.C14H16N4O2.2C14H16N4O.C13H15N5O.C13H16N4.C13H15N3O2S/c1-18(15(20)21-2)13-4-3-11-5-6-19(14(11)7-13)9-12-8-16-10-17-12;1-11(20)18(2)14-4-3-12-5-6-19(15(12)7-14)9-13-8-16-10-17-13;1-18(2)22(20,21)17-12-4-3-11-5-6-19(14(11)7-12)9-13-8-15-10-16-13;1-20-14(19)17-11-3-2-10-4-5-18(13(10)6-11)8-12-7-15-9-16-12;1-17(10-19)13-3-2-11-4-5-18(14(11)6-13)8-12-7-15-9-16-12;1-10(19)17-12-3-2-11-4-5-18(14(11)6-12)8-13-7-15-9-16-13;14-13(19)17-10-2-1-9-3-4-18(12(9)5-10)7-11-6-15-8-16-11;1-14-11-3-2-10-4-5-17(13(10)6-11)8-12-7-15-9-16-12;1-19(17,18)12-3-2-10-4-5-16(13(10)6-12)8-11-7-14-9-15-11/h3-4,7-8,10H,5-6,9H2,1-2H3,(H,16,17);3-4,7-8,10H,5-6,9H2,1-2H3,(H,16,17);3-4,7-8,10,17H,5-6,9H2,1-2H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,15,16)(H,17,19);2-3,6-7,9-10H,4-5,8H2,1H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,15,16)(H,17,19);1-2,5-6,8H,3-4,7H2,(H,15,16)(H3,14,17,19);2-3,6-7,9,14H,4-5,8H2,1H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,14,15)
InChIKeyLIPZOYVNGNGUSA-UHFFFAOYSA-N
XLogP15.82
TPSA575.57 Ų
H-Bond Donors15
H-Bond Acceptors31
Rotatable Bonds30
Heavy Atoms176
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002425.95
LogP ≤ 515.82
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate?
The IUPAC name of 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate (CID 159361739) is 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate.
What is the SMILES notation for 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate?
The canonical SMILES for 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate is CC(=O)N(C)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CN(C)S(=O)(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CN(C=O)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CNc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.COC(=O)N(C)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.COC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.CS(=O)(=O)c1ccc2c(c1)N(Cc1cnc[nH]1)CC2.NC(=O)Nc1ccc2c(c1)N(Cc1cnc[nH]1)CC2.
What is the InChIKey of 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate?
The InChIKey is LIPZOYVNGNGUSA-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H18N4O2.C15H18N4O.C14H19N5O2S.C14H16N4O2.2C14H16N4O.C13H15N5O.C13H16N4.C13H15N3O2S/c1-18(15(20)21-2)13-4-3-11-5-6-19(14(11)7-13)9-12-8-16-10-17-12;1-11(20)18(2)14-4-3-12-5-6-19(15(12)7-14)9-13-8-16-10-17-13;1-18(2)22(20,21)17-12-4-3-11-5-6-19(14(11)7-12)9-13-8-15-10-16-13;1-20-14(19)17-11-3-2-10-4-5-18(13(10)6-11)8-12-7-15-9-16-12;1-17(10-19)13-3-2-11-4-5-18(14(11)6-13)8-12-7-15-9-16-12;1-10(19)17-12-3-2-11-4-5-18(14(11)6-12)8-13-7-15-9-16-13;14-13(19)17-10-2-1-9-3-4-18(12(9)5-10)7-11-6-15-8-16-11;1-14-11-3-2-10-4-5-17(13(10)6-11)8-12-7-15-9-16-12;1-19(17,18)12-3-2-10-4-5-16(13(10)6-12)8-11-7-14-9-15-11/h3-4,7-8,10H,5-6,9H2,1-2H3,(H,16,17);3-4,7-8,10H,5-6,9H2,1-2H3,(H,16,17);3-4,7-8,10,17H,5-6,9H2,1-2H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,15,16)(H,17,19);2-3,6-7,9-10H,4-5,8H2,1H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,15,16)(H,17,19);1-2,5-6,8H,3-4,7H2,(H,15,16)(H3,14,17,19);2-3,6-7,9,14H,4-5,8H2,1H3,(H,15,16);2-3,6-7,9H,4-5,8H2,1H3,(H,14,15).
What are the key properties of 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate?
6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate has a molecular weight of 2425.95 g/mol, XLogP of 15.82, 30 rotatable bonds, 15 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 6-(dimethylsulfamoylamino)-1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindole;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]acetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylacetamide;N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylformamide;[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]urea;1-(1H-imidazol-5-ylmethyl)-N-methyl-2,3-dihydroindol-6-amine;1-(1H-imidazol-5-ylmethyl)-6-methylsulfonyl-2,3-dihydroindole;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]carbamate;methyl N-[1-(1H-imidazol-5-ylmethyl)-2,3-dihydroindol-6-yl]-N-methylcarbamate is sourced from PubChem (CID 159361739), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).